Reagents for assay development in tropical and vector-borne diseases are vital for improving diagnostics in these challenging areas of healthcare. These specialized antibodies and antigens facilitate the development of accurate assays for diseases like malaria, dengue, and Zika. By enabling early and precise detection, these reagents play a crucial role in disease management and outbreak control. Their use supports global health initiatives, enhancing diagnostic capabilities in endemic regions.